Literature DB >> 20841475

The role of telomeres and telomerase in cancer research.

Sheila A Stewart1, Alison A Bertuch.   

Abstract

The fourth AACR Special Conference on The Role of Telomeres and Telomerase in Cancer Research was held February 27 to March 2, 2010 in Fort Worth, TX. The meeting was organized to bring together those interested in the basic molecular mechanisms that govern telomere dynamics and stability with those interested in the clinical implications of telomere dysfunction and the use of telomeres and telomerase as therapeutic targets. The meeting was extremely successful as evidenced by the attendance and quality of the presentations. Indeed, several important themes emerged including (a) the intricate connection between the DNA replication and repair machineries in basic telomere replication and stability, (b) the complex interplay between the telomere-specific shelterin components and DNA repair proteins, (c) the nontelomeric functions of TERT in numerous cell types including stem cells, (d) a growing appreciation for the connection that exists between telomere maintenance deficiency states and diverse conditions such as idiopathic pulmonary fibrosis and hematopoietic malignancies, and (e) the successful progression of agents targeting telomerase directly and immunologically to phase III clinical trials. Evident at the meeting was the vibrant energy that permeates the telomere field and the important biological and medical findings that it continues to yield.
© 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20841475      PMCID: PMC2948573          DOI: 10.1158/0008-5472.CAN-10-1373

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.

Authors:  Rosa M Marion; Katerina Strati; Han Li; Agueda Tejera; Stefan Schoeftner; Sagrario Ortega; Manuel Serrano; Maria A Blasco
Journal:  Cell Stem Cell       Date:  2009-02-06       Impact factor: 24.633

2.  Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells.

Authors:  Yong Zhao; Agnel J Sfeir; Ying Zou; Christen M Buseman; Tracy T Chow; Jerry W Shay; Woodring E Wright
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

3.  Short telomeres are preferentially elongated by telomerase in human cells.

Authors:  Bethan Britt-Compton; Rebecca Capper; Jan Rowson; Duncan M Baird
Journal:  FEBS Lett       Date:  2009-08-29       Impact factor: 4.124

4.  Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.

Authors:  Agnel Sfeir; Settapong T Kosiyatrakul; Dirk Hockemeyer; Sheila L MacRae; Jan Karlseder; Carl L Schildkraut; Titia de Lange
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

Review 5.  Dissecting the non-canonical functions of telomerase.

Authors:  E K Parkinson; C Fitchett; B Cereser
Journal:  Cytogenet Genome Res       Date:  2009-01-30       Impact factor: 1.636

6.  Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice.

Authors:  Paula Martínez; Maria Thanasoula; Purificación Muñoz; Chunyan Liao; Agueda Tejera; Carolyn McNees; Juana M Flores; Oscar Fernández-Capetillo; Madalena Tarsounas; Maria A Blasco
Journal:  Genes Dev       Date:  2009-08-13       Impact factor: 11.361

7.  Ku86 represses lethal telomere deletion events in human somatic cells.

Authors:  Yongbao Wang; Goutam Ghosh; Eric A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

Review 8.  Telomere length regulation: coupling DNA end processing to feedback regulation of telomerase.

Authors:  David Shore; Alessandro Bianchi
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

9.  Multiple roles for MRE11 at uncapped telomeres.

Authors:  Yibin Deng; Xiaolan Guo; David O Ferguson; Sandy Chang
Journal:  Nature       Date:  2009-07-26       Impact factor: 69.504

10.  An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.

Authors:  Yoshiko Maida; Mami Yasukawa; Miho Furuuchi; Timo Lassmann; Richard Possemato; Naoko Okamoto; Vivi Kasim; Yoshihide Hayashizaki; William C Hahn; Kenkichi Masutomi
Journal:  Nature       Date:  2009-08-23       Impact factor: 49.962

View more
  9 in total

1.  Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk.

Authors:  Kathryn L Terry; Shelley S Tworoger; Allison F Vitonis; Jason Wong; Linda Titus-Ernstoff; Immaculata De Vivo; Daniel W Cramer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-01-20       Impact factor: 4.254

2.  A prospective analysis of telomere length and pancreatic cancer in the alpha-tocopherol beta-carotene cancer (ATBC) prevention study.

Authors:  Shannon M Lynch; Jacqueline M Major; Richard Cawthon; Stephanie J Weinstein; Jarmo Virtamo; Qing Lan; Nathaniel Rothman; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Int J Cancer       Date:  2013-06-14       Impact factor: 7.396

3.  Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.

Authors:  Wei Guo; Jianjun Lu; Meng Dai; Taihua Wu; Zhenlong Yu; Jingshu Wang; Wangbing Chen; Dingbo Shi; Wendan Yu; Yao Xiao; Canhui Yi; Zhipeng Tang; Tingting Xu; Xiangsheng Xiao; Yuhui Yuan; Quentin Liu; Guangwei Du; Wuguo Deng
Journal:  Oncotarget       Date:  2014-10-15

4.  Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter.

Authors:  Weibo Yu; Xiaotian Qin; Yusheng Jin; Yawei Li; Chintda Santiskulvong; Victor Vu; Gang Zeng; Zuofeng Zhang; Michelle Chow; Jianyu Rao
Journal:  Oncotarget       Date:  2017-01-31

5.  Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl)methanone through upregulating hTERT induces cell apoptosis and ERS.

Authors:  Xiu Cheng; Jing Bo Shi; Hao Liu; Liu Zeng Chen; Yang Wang; Wen Jian Tang; Xin Hua Liu
Journal:  Cell Death Dis       Date:  2017-08-24       Impact factor: 8.469

6.  Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.

Authors:  Xing Chen; Gao-Feng Zha; Jie Quan Wang; Xin-Hua Liu
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

7.  Association between leukocyte telomere length and the risk of pancreatic cancer: Findings from a prospective study.

Authors:  Hung N Luu; Joyce Y Huang; Renwei Wang; Jennifer Adams-Haduch; Aizhen Jin; Woon-Puay Koh; Jian-Min Yuan
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

8.  Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers.

Authors:  Yongxing Wu; Liang Shi; Yuelei Zhao; Pu Chen; Rongrong Cui; Meiju Ji; Nongyue He; Maode Wang; Gang Li; Peng Hou
Journal:  NPJ Precis Oncol       Date:  2021-01-22

9.  Urine telomerase for diagnosis and surveillance of bladder cancer.

Authors:  Angela Lamarca; Jorge Barriuso
Journal:  Adv Urol       Date:  2012-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.